Comparison · NCT02100722-b3a4d1b1
FFR Guided PCI vs CABG: MACCE
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. FFR Guided PCI vs CABG: MACCE. Trial comparisons, record NCT02100722-b3a4d1b1. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02100722-b3a4d1b1
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.248 | 0.219 | 0.28 | wilson | |
| Risk in group 2 | 0.176 | 0.151 | 0.205 | wilson | |
| Risk difference, group 1 minus group 2 | 0.072 | 0.0307 | 0.113 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.41 | 1.15 | 1.72 | log | |
| Odds ratio, group 1 over group 2 | 1.54 | 1.2 | 1.98 | log | |
| Number needed to treat, for one more participant with the outcome on FFR Guided PCI than on CABG | 13.9 | 8.84 | 32.6 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | FFR Guided PCI | Patients undergoing PCI with measured FFR ≤0.80 have PCI performed with Medtronic Resolute Integrity (or Onyx) drug-eluting stent. | 188 | 757 | OG000 |
| Group 2 | CABG | CABG performed per clinical routine (both off-pump and on-pump surgery acceptable). | 131 | 743 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- MACCE
- Description
- Death, MI, stroke and any repeat revascularization (MACCE) rate at 5 years
- Time frame
- 5 years
- Population
- Intention-to-Treat Population
Source ClinicalTrials.gov
Trial
- Title
- A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
- NCT number
- NCT02100722
- Phases
- NA
- Conditions
- Coronary Disease, Coronary Stenosis
- Interventions
- FFR guided PCI, CABG, Resolute Integrity Stent, Resolute Onyx Stent
- Lead sponsor
- Stanford University
- Results first posted
- 2022-01-20
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02100722?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02100722-b3a4d1b1